Cooperative Agreement To Support Building Global Capacity for the Surveillance and Monitoring of Counterfeit/Falsified Medicines and Supply Chain Threats

摘要

The Food and Drug Administration (FDA) is announcing its intention to accept and consider a single source application for award of a cooperative agreement to the World Health Organization (WHO) in support of building a global surveillance and monitoring system for combating counterfeit/falsified medicines and risks and breaches in the supply.